share_log

Benchmark Maintains Speculative Buy on Genelux, Raises Price Target to $38

Benzinga ·  Jun 9, 2023 22:40

Benchmark analyst Bruce Jackson maintains Genelux (NASDAQ:GNLX) with a Speculative Buy and raises the price target from $10 to $38.

The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment